Cardiovascular — API & Bulk Drug Suppliers in India

dihydropyridine calcium-channel blocker — tablet formulations for hypertension and angina.

cardioselective beta-blocker — tablet formulations for hypertension and chronic heart failure.

cardiac glycoside — tablet formulations for atrial fibrillation and heart failure.

non-dihydropyridine calcium-channel blocker — tablet formulations for angina and rate control.

ACE inhibitor — tablet formulations for hypertension and heart failure.

loop diuretic — tablet and injection formulations for oedema in heart, liver and kidney disease.

thiazide diuretic — tablet formulations for hypertension, usually in combinations.

angiotensin II receptor blocker — tablet formulations for hypertension and diabetic nephropathy.

ACE inhibitor — tablet formulations for hypertension and post-infarction care.

angiotensin II receptor blocker — tablet formulations for hypertension and diabetic nephropathy.

cardioselective beta-blocker, extended-release salt — tablet formulations for hypertension, angina and heart failure.

angiotensin II receptor blocker — tablet formulations for hypertension.

non-selective beta-blocker — tablet formulations for hypertension, tremor, migraine prophylaxis and anxiety symptoms.

ACE inhibitor — tablet formulations for hypertension and cardiovascular prevention.

statin HMG-CoA reductase inhibitor — tablet formulations for hypercholesterolaemia.

statin HMG-CoA reductase inhibitor — tablet formulations for hypercholesterolaemia and cardiovascular prevention.

aldosterone-antagonist diuretic — tablet formulations for heart failure, ascites and resistant hypertension.

angiotensin II receptor blocker — tablet formulations for hypertension and cardiovascular risk reduction.

loop diuretic — tablet formulations for oedema and heart failure.

non-dihydropyridine calcium-channel blocker — tablet formulations for angina, hypertension and supraventricular arrhythmia.

carbonic-anhydrase inhibitor — tablet and injection formulations for glaucoma, altitude sickness and oedema.

dual endothelin-receptor antagonist — tablet formulations for pulmonary arterial hypertension.

angiotensin II receptor blocker — tablet formulations for hypertension and heart failure.

non-selective beta-blocker with alpha-blockade — tablet formulations for heart failure and hypertension.

thiazide-like diuretic — tablet formulations for hypertension, alone and in combinations.

antiplatelet and vasodilator — tablet formulations, typically with aspirin, for stroke prevention.

alpha-1 blocker — tablet formulations for hypertension and benign prostatic hyperplasia.

multichannel antiarrhythmic — tablet formulations for atrial fibrillation maintenance.

selective aldosterone antagonist — tablet formulations for heart failure and post-infarction care.

cholesterol-absorption inhibitor — tablet formulations, alone and with statins, for hypercholesterolaemia.

PPAR-alpha agonist fibrate — tablet and capsule formulations for hypertriglyceridaemia.

thiazide-like diuretic — tablet formulations for hypertension.

long-acting nitrate vasodilator — extended-release tablet formulations for angina prophylaxis.

funny-channel (If) inhibitor — tablet formulations for angina and heart-failure rate control.

calcium sensitiser inotrope — infusion formulations for acute decompensated heart failure.

central alpha-2 agonist antihypertensive — tablet formulations for hypertension in pregnancy.

cardioselective beta-blocker with NO activity — tablet formulations for hypertension and heart failure.

short-acting nitrate vasodilator — sublingual tablet and spray formulations for acute angina.

statin HMG-CoA reductase inhibitor — tablet formulations for hypercholesterolaemia.

thienopyridine antiplatelet — tablet formulations for post-angioplasty stent cover.

late-sodium-current inhibitor — extended-release tablet formulations for chronic angina.

beta-blocker with class III antiarrhythmic action — tablet formulations for arrhythmia maintenance.

direct-acting P2Y12 antiplatelet — tablet formulations for acute coronary syndromes.

Statin API for cholesterol-lowering tablets, amorphous and crystalline.

endothelin receptor antagonist — tablet formulations for pulmonary arterial hypertension.

class III antiarrhythmic — tablet and injection formulations for ventricular and atrial arrhythmias.

cardioselective beta blocker — tablet formulations for hypertension and angina.

first ACE inhibitor — tablet formulations for hypertension and heart failure.

carnitine supplement for fat metabolism — tablet, solution and injection formulations for carnitine deficiency and dialysis care.

dual endothelin receptor antagonist — tablet formulations for pulmonary arterial hypertension.

cardioselective beta blocker — tablet formulations for hypertension, angina and heart failure.

dihydropyridine calcium channel blocker — tablet and capsule formulations for hypertension and angina.

high-potency statin — tablet formulations for LDL-cholesterol reduction.

ARNI — neprilysin inhibitor plus ARB — tablet formulations for chronic heart failure with reduced ejection fraction.